← Back

Wire · technology

AI An Enrollment Game Changer?

Published

23 October 2026

Topic

technology

◆ Sectors

AI Frontier ModelsDrug DiscoveryHealthtech Infrastructure

◆ Geography

United States

◆ Source

Read at appliedclinicaltrialsonline.com →

◆ Verified

Fusion42 · 24 October 2026 · Fusion42 review

AI is being applied to clinical trial enrollment to improve prediction and reduce delays and costs, addressing a major bottleneck in study execution. Experts in clinical development see a shift towards embedding AI as a continuous operating system rather than isolated tools.

This Wire brief sits within Fusion42's coverage of AI Frontier Models, Drug Discovery and Healthtech Infrastructure.

◆ ◆ The Wire takeaway

You face a new door in clinical trial enrolment as AI moves beyond isolated tools to become your underlying operational platform. This shift lets you cut costs and delays by replacing guesswork with data-driven workflows.

◆ Coverage

1 source · 23 Oct 2026

◆ Related on Wire

◆ Topics

AI Frontier ModelsDrug DiscoveryHealthtech Infrastructureaiclinical-trialsenrollmentdigital-healthstudy-execution